{"title":"The therapist as a travelling companion to the chronically ill: hypnosis and cancer related symptoms†","authors":"Hansjörg Ebell","doi":"10.1002/ch.348","DOIUrl":null,"url":null,"abstract":"<p>The complex interaction of pain, other symptoms and suffering in cancer patients requires a treatment approach that integrates psychological as well as pharmacological interventions. The supplementation of a pharmacological pain treatment concept based on WHO-guidelines by the use of self hypnosis was examined in a controlled clinical follow up study: 61 of 342 patients with cancer related pain referred to the Interdisciplinary Pain Unit of Munich University Clinic were included. In a cross-over design they were randomly assigned to two different successions of treatments after a 2-week period of establishing optimal medication: either AB (A: using self- hypnosis and analgesics, followed by B: pharmacological treatment alone, 4 weeks each) or BA (B: continuing pharmacological treatment alone and then A: using additional self-hypnosis). Patients themselves evaluated therapeutic effectiveness with the help of visual analogue scales (VAS) in a ‘pain diary’ for a total of 10 weeks. On account of a carryover-effect caused by the beneficial effects of self-hypnosis the ‘cross-over’ did not show statistical significance. Using a parallel design we found a statistically significant reduction of pain and suffering after the first four weeks for treatment A (with self-hypnosis) in comparison to treatment B (without self-hypnosis). The utilization of hypnosis requires an intensive subjective exchange over a period of time between the patient and the therapist, who embark as travelling companions on a journey through uncharted territory. Three case reports serve as an example for three different ‘time windows’ of this travelling companionship of therapists and patients: short term/crisis intervention, cooperation for several weeks/coping enhancement, and long term/psychotherapy. Copyright © 2008 British Society of Experimental & Clinical Hypnosis. Published by John Wiley & Sons, Ltd.</p>","PeriodicalId":88229,"journal":{"name":"Contemporary hypnosis : the journal of the British Society of Experimental and Clinical Hypnosis","volume":"25 1","pages":"46-56"},"PeriodicalIF":0.0000,"publicationDate":"2008-02-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1002/ch.348","citationCount":"15","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Contemporary hypnosis : the journal of the British Society of Experimental and Clinical Hypnosis","FirstCategoryId":"1085","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/ch.348","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 15
Abstract
The complex interaction of pain, other symptoms and suffering in cancer patients requires a treatment approach that integrates psychological as well as pharmacological interventions. The supplementation of a pharmacological pain treatment concept based on WHO-guidelines by the use of self hypnosis was examined in a controlled clinical follow up study: 61 of 342 patients with cancer related pain referred to the Interdisciplinary Pain Unit of Munich University Clinic were included. In a cross-over design they were randomly assigned to two different successions of treatments after a 2-week period of establishing optimal medication: either AB (A: using self- hypnosis and analgesics, followed by B: pharmacological treatment alone, 4 weeks each) or BA (B: continuing pharmacological treatment alone and then A: using additional self-hypnosis). Patients themselves evaluated therapeutic effectiveness with the help of visual analogue scales (VAS) in a ‘pain diary’ for a total of 10 weeks. On account of a carryover-effect caused by the beneficial effects of self-hypnosis the ‘cross-over’ did not show statistical significance. Using a parallel design we found a statistically significant reduction of pain and suffering after the first four weeks for treatment A (with self-hypnosis) in comparison to treatment B (without self-hypnosis). The utilization of hypnosis requires an intensive subjective exchange over a period of time between the patient and the therapist, who embark as travelling companions on a journey through uncharted territory. Three case reports serve as an example for three different ‘time windows’ of this travelling companionship of therapists and patients: short term/crisis intervention, cooperation for several weeks/coping enhancement, and long term/psychotherapy. Copyright © 2008 British Society of Experimental & Clinical Hypnosis. Published by John Wiley & Sons, Ltd.
作为慢性病患者旅行伴侣的治疗师:催眠和癌症相关症状†
癌症患者的疼痛、其他症状和痛苦的复杂相互作用需要一种综合心理和药物干预的治疗方法。在一项对照临床随访研究中,通过使用自我催眠来补充基于世卫组织指南的药理学疼痛治疗概念:在慕尼黑大学诊所跨学科疼痛科转诊的342名癌症相关疼痛患者中,包括61名患者。在交叉设计中,他们被随机分配到两种不同的连续治疗中,在两周的时间内建立最佳药物:AB (a:使用自我催眠和止痛药,然后B:单独药物治疗,每个4周)或BA (B:继续单独药物治疗,然后a:使用额外的自我催眠)。患者自己用视觉模拟量表(VAS)在“疼痛日记”中评估治疗效果,共持续10周。由于自我催眠的有益效果所引起的结转效应,“交叉”没有显示出统计学意义。采用平行设计,我们发现在治疗a(自我催眠)的头四周后,与治疗B(不自我催眠)相比,疼痛和痛苦在统计学上有显著减少。催眠的使用需要在一段时间内,病人和治疗师之间进行密集的主观交流,他们就像旅行同伴一样,在未知的领域中旅行。三个案例报告作为治疗师和患者旅行陪伴的三个不同“时间窗口”的例子:短期/危机干预,几周的合作/应对增强,以及长期/心理治疗。版权所有©2008英国实验学会;临床催眠。John Wiley &出版;儿子,有限公司
本文章由计算机程序翻译,如有差异,请以英文原文为准。